HCV anti-core monoclonal antibodies
US7049060B2 · kind B2 · utility
6Cited by
1References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 10, 2002 |
| Grant date | May 23, 2006 |
| Priority date | — |
| Expiry date | Sep 13, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Monoclonal antibodies that specifically bind to HCV core antigen. Also provided are hybridoma cell lines which secrete these antibodies, methods for making and using these antibodies, including kits that include these antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.